Bispecific killer cell engagers, or BiKEs, are an alternative to BiTEs in that they target tumor antigens along with the NK marker CD16, resulting in persistent NK cell activation and cytotoxicity towards tumor cells. The gene discussed is FCGR3A; the disease is neoplasm.